133 related articles for article (PubMed ID: 6186356)
1. Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer; 1983 Apr; 51(8):1348-52. PubMed ID: 6186356
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Rodgers RW; Gamble JF; Loh KK; Shullenberger CC
Cancer; 1980 Dec; 46(11):2349-55. PubMed ID: 6159961
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Straus DJ; Myers J; Koziner B; Lee BJ; Clarkson BD
Cancer Chemother Pharmacol; 1983; 11(2):80-5. PubMed ID: 6194913
[TBL] [Abstract][Full Text] [Related]
4. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in the treatment of Hodgkin's disease.
Canellos GP; Come SE; Skarin AT
Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
[No Abstract] [Full Text] [Related]
6. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Tannir N; Hagemeister F; Velasquez W; Cabanillas F
J Clin Oncol; 1983 Jul; 1(7):432-9. PubMed ID: 6199478
[TBL] [Abstract][Full Text] [Related]
7. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Bonadonna G; Santoro A; Bonfante V; Valagussa P
Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Santoro A; Bonfante V; Bonadonna G
Ann Intern Med; 1982 Feb; 96(2):139-43. PubMed ID: 6174060
[TBL] [Abstract][Full Text] [Related]
9. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
10. The cure of Hodgkin's disease with drugs.
DeVita VT; Hubbard SM; Moxley JH
Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
[No Abstract] [Full Text] [Related]
11. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Carella AM; Congiu AM; Gaozza E; Mazza P; Ricci P; Visani G; Meloni G; Cimino G; Mangoni L; Coser P
J Clin Oncol; 1988 Sep; 6(9):1411-6. PubMed ID: 2458439
[TBL] [Abstract][Full Text] [Related]
12. More than MOPP for advanced Hodgkin's disease?
Mayer RJ
N Engl J Med; 1982 Apr; 306(13):800-2. PubMed ID: 6174866
[No Abstract] [Full Text] [Related]
13. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Bonadonna G; Valagussa P; Santoro A
Ann Intern Med; 1986 Jun; 104(6):739-46. PubMed ID: 2422994
[TBL] [Abstract][Full Text] [Related]
14. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Papa G; Mandelli F; Anselmo AP; De Luca AM; Maurizienrici R; Mauro F; Testi AM; Amadori S; Biagini C
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):803-6. PubMed ID: 6185342
[No Abstract] [Full Text] [Related]
15. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Prosnitz LR; Farber LR; Kapp DS; Scott J; Bertino JR; Fischer JJ; Cadman EC
J Clin Oncol; 1988 Apr; 6(4):603-12. PubMed ID: 2451712
[TBL] [Abstract][Full Text] [Related]
16. ABVD chemotherapy in the treatment of Hodgkin's disease.
Bonadonna G; Santoro A
Cancer Treat Rev; 1982 Mar; 9(1):21-35. PubMed ID: 6175409
[No Abstract] [Full Text] [Related]
17. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Santoro A; Bonadonna G; Bonfante V; Valagussa P
N Engl J Med; 1982 Apr; 306(13):770-5. PubMed ID: 6174865
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Jones SE; Haut A; Weick JK; Wilson HE; Grozea P; Fabian CJ; McKelvey E; Byrne GE; Hartsock R; Dixon DO; Coltman CA
Cancer; 1983 Apr; 51(8):1339-47. PubMed ID: 6186355
[No Abstract] [Full Text] [Related]
19. Alternating drug combinations for advanced Hodgkin's disease.
N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
[No Abstract] [Full Text] [Related]
20. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Glick JH; Tsiatis A
Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
